- Home
- TNGX vs VTLE Comparison
TNGX vs VTLE Comparison
Compare TNGX & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- VTLE
- Stock Information
- Founded
- TNGX 2014
- VTLE 2006
- Country
- TNGX United States
- VTLE United States
- Employees
- TNGX N/A
- VTLE N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- VTLE
- Sector
- TNGX Health Care
- VTLE
- Exchange
- TNGX Nasdaq
- VTLE Nasdaq
- Market Cap
- TNGX 723.2M
- VTLE 592.9M
- IPO Year
- TNGX N/A
- VTLE 2011
- Fundamental
- Price
- TNGX $7.35
- VTLE $16.52
- Analyst Decision
- TNGX Strong Buy
- VTLE Hold
- Analyst Count
- TNGX 6
- VTLE 11
- Target Price
- TNGX $10.00
- VTLE $25.22
- AVG Volume (30 Days)
- TNGX 1.5M
- VTLE 2.1M
- Earning Date
- TNGX 11-05-2025
- VTLE 11-05-2025
- Dividend Yield
- TNGX N/A
- VTLE N/A
- EPS Growth
- TNGX N/A
- VTLE N/A
- EPS
- TNGX N/A
- VTLE N/A
- Revenue
- TNGX $24,296,000.00
- VTLE $1,935,411,000.00
- Revenue This Year
- TNGX $20.42
- VTLE $1.16
- Revenue Next Year
- TNGX N/A
- VTLE N/A
- P/E Ratio
- TNGX N/A
- VTLE N/A
- Revenue Growth
- TNGX N/A
- VTLE 5.26
- 52 Week Low
- TNGX $1.03
- VTLE $12.30
- 52 Week High
- TNGX $10.81
- VTLE $36.72
- Technical
- Relative Strength Index (RSI)
- TNGX 60.63
- VTLE 49.58
- Support Level
- TNGX $6.38
- VTLE $15.93
- Resistance Level
- TNGX $6.90
- VTLE $17.18
- Average True Range (ATR)
- TNGX 0.44
- VTLE 0.85
- MACD
- TNGX 0.00
- VTLE -0.04
- Stochastic Oscillator
- TNGX 94.14
- VTLE 30.77
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About VTLE Vital Energy Inc. par value $0.01 per share
Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.